However, significantly higher levels of T cells were detected

in NSG mice that were implanted in the renal subcapsular space of the kidneys compared to the subcutaneous site (Fig. 4b). No structural differences were observed between thymus tissues recovered from either site (Fig. 4d–k), although the size of the tissue recovered from the subcutaneous site was consistently smaller. Moreover, well-formed Hassall’s corpuscles, a structure characteristic of human thymus, were detected readily within the thymic medulla of tissues recovered from either renal subcapsular or subcutaneous sites (Fig. 4e,i,g,k) [61]. Significantly higher levels of B cells were detected in NSG mice implanted in the subcutaneous site (Fig. 4c), although no significant differences were detected in human IgM and IgG in the plasma of mice from either group (Fig. 4l,m). learn more These findings indicate that subcutaneous implantation of human fetal thymic tissues is less efficient than subrenal implantation for generation of human T cells in the BLT model.

To evaluate the long-term maintenance of human cell chimerism Dabrafenib mouse in BLT mice, NSG mice were irradiated (200 cGy), implanted with human thymic and liver tissues and injected with human HSC as described in Materials and methods. Between 26 and 28 weeks post-implant, NSG–BLT mice were screened for total human cell chimerism (CD45+ cells) for human T cell (CD3+ cells) and B cell (CD20+ cells) development in the blood and spleen (Fig. 5a–c). Human leucocyte levels were very high in mice this website that had been engrafted for greater than 25 weeks. However, both T and B cells were transitioning to an activated phenotype at these later time-points. For example, there was a significant decrease in the percentage of CD45RA+ CD4 and CD8 T cells in the blood at 26 weeks compared

to 12 weeks (Fig. 5d). CD45RA is not expressed exclusively by naive T cells, but still provides a reliable estimation of the activation status [62]. In the spleen of BLT mice, the average percentage of CD45RA+ CD4 and CD8 T cells was less than 60% between 26 and 28 weeks after implant (Fig. 5e). Moreover, there was a significant increase in human IgM and IgG levels in plasma of BLT mice at 26 to 28 weeks after implant compared to 12 and 19 weeks (Fig. 5f,g). The activation of the human immune system also correlated with a decrease in platelet (PLT), red blood cell (RBC) and haemoglobin (HGB) values (Fig. 5h–j, respectively). Together these data suggest that human cell chimerism is maintained long term in BLT mice, but the human immune system becomes activated spontaneously. NSG–BLT mice support the human immune system engraftment for an extended time-frame; however, these animals have been reported to develop a xeno-GVHD late after implant [54]. At approximately week 20 post-implant, NSG–BLT mice generated in our laboratory displayed a significantly increased rate of mortality compared to NSG mice that were only irradiated (P = 0·026, Fig.